An informative article on what the "norm" is in reporting new cancer drug results.  No mention of CTIX, but I am heartened that Leo and Dr Menon don't seem to be a part of this trend toward "inflation" in any PRs.  Speaks volumes for their credibility.

http://www.pharmpro.com/news/2013/01/nusiness...-Trials%2f